Exagen Inc. XGN Cash Flow Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| -$3.97M+15.1% | -$4.67M+34.1% | -$7.09M-59.7% | -$4.44M-18.3% | -$3.75M+0.2% | ||
| $655K-7.1% | $705K+18.9% | $593K+33.9% | $443K+6.2% | $417K-3.7% | ||
| $133K+1.5% | $131K+4.0% | $126K+59.5% | $79K+88.1% | $42K0.0% | ||
| $4.92M— | —— | —— | —— | $6.89M— | ||
| -$41K-107% | $587K-43.1% | $1.03M+157% | -$1.81M-883% | $231K-90.1% | ||
| -$1.56M-329% | $681K-42.3% | $1.18M+715% | -$192K+86.5% | -$1.42M— | ||
| -$172K+42.3% | -$298K-44.7% | -$206K+4.6% | -$216K-200% | -$72K-454% | ||
| $99K— | $0+100% | -$69K-1,625% | -$4K+94.6% | -$74K-5.7% | ||
| $6K— | —— | -$375K-368% | $140K-2.1% | $143K-80.5% | ||
| -$295K-2.4% | -$288K-4.7% | -$275K-1.9% | -$270K-2.7% | -$263K-2.7% | ||
| -$10.42M-246% | -$3.01M— | —— | -$2.89M+73.0% | -$10.67M— | ||
| $228K+418% | $44K-84.0% | $275K+31.6% | $209K+85.0% | $113K-22.6% | ||
| $0-100% | $9K— | —— | —— | $6K— | ||
| -$228K-551% | -$35K+87.3% | -$275K-31.6% | -$209K-95.3% | -$107K+26.7% | ||
| $168K+1.8% | $165K+1.9% | $162K+2.5% | $158K+47.7% | $107K— | ||
| $295K— | —— | —— | $18.58M+9,283% | $198K— | ||
| $189K+4.4% | $181K+4.0% | $174K+255% | $49K-45.6% | $90K-18.9% | ||
| $0— | $0-100% | $199K-67.1% | $605K+831% | $65K— | ||
| -$62K— | $0-100% | $2.95M-86.5% | $21.93M+34,370% | -$64K+70.4% | ||
| -$10.71M— | —— | $5.62M-70.2% | $18.84M+274% | -$10.84M— | ||
| $856K-2.7% | $880K-0.6% | $885K+7.9% | $820K+104% | $402K-2.4% | ||
| $133K+1.5% | $131K+4.0% | $126K+59.5% | $79K+88.1% | $42K0.0% | ||
| $661K+139% | $277K-7.7% | $300K+50.0% | $200K— | $0— | ||
| $599K-0.2% | $600K-2.0% | $612K+31.3% | $466K+5.9% | $440K+6.0% | ||
| -$1.56M-329% | $681K-42.3% | $1.18M+715% | -$192K+86.5% | -$1.42M— | ||
| -$295K-2.4% | -$288K-4.7% | -$275K-1.9% | -$270K-2.7% | -$263K-2.7% | ||
| $1.14M— | —— | -$560K+29.6% | -$796K-39,700% | -$2K-100% | ||
| $256K+2.4% | $250K— | —— | —— | $234K+2.6% | ||
| $99K— | $0+100% | -$69K-1,625% | -$4K+94.6% | -$74K-5.7% | ||
| $0-100% | $9K— | —— | —— | $6K— | ||
| $189K+4.4% | $181K+4.0% | $174K+255% | $49K-45.6% | $90K-18.9% | ||
| $0— | $0-100% | $199K-67.1% | $605K+831% | $65K— | ||
| $295K— | $0-100% | $199K+19,800% | $1K-99.5% | $198K— | ||
| $168K+1.8% | $165K+1.9% | $162K+2.5% | $158K+47.7% | $107K+1.9% | ||
| $72K+800% | $8K-52.9% | $17K+110% | -$176K-200% | $176K-74.7% | ||
| —— | $819.75K0.0% | $819.75K0.0% | $819.75K0.0% | $819.75K— | ||
| -$882K— | —— | $2.67M+510% | $438K— | $0— | ||
| $6K— | —— | -$375K-368% | $140K-2.1% | $143K-80.5% | ||
| -$295K-2.4% | -$288K-4.7% | -$275K-1.9% | -$270K-2.7% | -$263K-2.7% | ||
| $0— | $0-100% | $2.55M+50,880% | $5K-99.3% | $677K— | ||
| -$10.65M-248% | -$3.06M— | —— | -$3.09M+71.3% | -$10.78M— | ||
| -$10.65M-248% | -$3.06M— | —— | -$3.09M+71.3% | -$10.78M— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Exagen Inc. generate?
- Exagen Inc. (XGN) generated -$27.0M in operating cash flow over the trailing twelve months.
- What is Exagen Inc.'s free cash flow?
- After $756.0K of capital expenditures, Exagen Inc.'s free cash flow was -$27.6M over the trailing twelve months, down 96.9% year over year.
- Where does Exagen Inc.'s cash flow data come from?
- Every line is extracted from Exagen Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
